Incanthera Share Chat (INC.PL)

Having said that, our new CEO did structure a £250k facility of convertible notes to accelerate getting our product to market so we can’t complain in that sense.

I just don’t like when company’s don’t give shareholders their chance to participate because it’s pure dilution for us.

What I don’t like about that is : “adding that directors and management would provide additional financial support if required.”

Tim has been an absolute useless *unt here as he has at immupharma, but if they want to raise funds it’s a licence for them to offer some cheap equity to themselves at a discount while we all get diluted and they all increase ownership.

Https://www.proactiveinvestors.co.uk/companies/news/1089801/incanthera-remains-in-talks-with-three-distribution-partners-as-skincare-sales-make-slow-start-1089801.html

https://www.proactiveinvestors.co.uk/companies/news/1093433/incanthera-shares-jump-21-after-it-acquires-swiss-skincare-brand-and-appoints-new-chief-executive-update-1093433.html

I had missed these articles thought the deal to buy Énielle was positive - the management had controlled the dilution they raised some money but we got a second asset and spend does not seem excessive? and they have been under a lot of pressure, i have seen other managements not being as responsible and raised at 2p i bought on an average price of 6p so down a lot and i persuaded my girlfriend to buy at 25p so she is not impressed! but should i hope create a short term floor and crucially in the first article talks continue with 3 parties on distribution, so i am relieved that we are still in the game and there is everything still to play for to turn this around

The good news is that we have a leader working full time for the company rather than someone with 2 businesses to run. Also, it seems that Robertson was instrumental in bringing about the Watson arrangement. So his contacts were good. We now have someone with skin in the game.

Now everything hinges upon marketing. I think the products are unique and excellent. How are they going to be sold? Will Robertson be able to deliver?

The board needs to be changed to get rid of lightweights and associated expense. An expert in cosmetic marketing with good contacts is the person I would want.

It’s all a breath of fresh air. Let’s hope he can deliver. If he does we will all look back at this share price with longing.

Share holders need to start seeing a difference with the new management, an interview, PR, something to get a bit of interest going.

Its good to hear everyone's interested.

I am still struggling to join all the dots and add up all the sums. i don't think INCAN have acquired Enielle btw - its more the other way round.

some TR1s will be interesting to see...but anyway I've already posted more than enough without having sat down and looked a lot more carefully.

I think the buy out of Enielle could be a good move, lets face it with the management we had and the routing we went down it was a failure, you can have the best product in the world but if you don't have the experience in selling it and getting it out there then it does nothing.

Enielle has really for years been creating a serum and not really sold anything, but has lots of science and testing behind it, when you check there website after using it the results look visible in weeks which is quite impressive, before and after pictures.

There seems to be new products also like the suncare spray coming soon at SPF 50.

from co-pilot

2016 – Founded Enielle is established in Zurich as a premium skincare startup focused on lectin‑based formulations.

2017–2020 – R&D Phase Development of the T‑Mero‑Protect® ingredient, clinical testing, and formulation refinement.

2021–2024 – Pre‑launch & soft‑launch Small‑batch production, clinical studies, website launch, limited online availability.

2025 – Limited commercial availability Product can be purchased online, but sales volume remains very low.

2026 – Acquisition by Incanthera Enielle becomes part of Incanthera’s dermatology portfolio.

Skin and Cell has basically bought a company that has done all the work, trials and testing and serum that is clinical tested, also £3 million has been spent to get Enielle to this stage.

The management team going forward needs to relook at there website, i personally think the Enielle website looks more serious, has the before and after pictures to help plus information and the Skin + Cell just comes across to focus on young girls who can not afford these prices.

Enielle comes across Elegant, luxury‑skincare energy.

Skin+CELL — comes across, Clinical, biotech

Both have a very high pricing range that is not affordable for most people out there, a lot needs to be worked on if we are going to connect and sell.

As we have a new management team, I have asked the company going forward what will be done and the company is working on interviews and POD casts out there and better communication is required.

We also need clear strategy going forward.

I think we should see a steady rise back to 4-5p short term now we have secured a future and a bit more of a promising route to market. Who knows, maybe inc could end up being a huge success from here!

Vasc

don't think he can take the company private by himself.

fella would need a majority shareholding. which he doesn't have. even after the dilution.

for now the new owner is also a significant shareholder. which for many small caps is a good sign.

as to his plans...we should talk to him. or perhaps he'll do an interview and talk to us.

Good morning, Vascular, Rookie1, Geraldus, Howard249 & XsViolet,

Of course, I echo your delight, relief, hope, concerns and scepticism: Thank you.

Whilst the "changes" are blessed relief, I hope that the the ringing-in of these changes is not going simply a reflection of the machinations of our own Parliament. Long as the announcement is, there was insufficient noise about Working Capital. Hope is pinned on Stuart to address that aspect and to get that right.

As Andy Burnham stated, yesterday, on Question Time, "Things have got to change", and one thing that really has to change is not just a driver on a bus that may appear to some to be on a "Summer Holiday", but, for instance, the supervision of trading in the market.

I'm still bemused by the striking price of the transaction.

Everything crossed that Stuart will bring real drive and achieve success for both the Company and disillusioned shareholders and not more puff.

Vaya con dios.

In the real world, even complicated, small deals such as this, take time and are costly. How long have discussions leading to this transaction been taking place?

Initially I was over the moon with that RNS, then I read vasculars post and was brought back to my senses. Tim’s a slippery little snake and he’s slimed out of this one dressing it up as a win.

Hopefully that’s just me being pessimistic and these guys do want to turn the company around. Someone with half a business brain should be able to get Skin+cell producing £250k profit easy enough imo, it’s a great product, it’s just had a clueless leader running the company for so long.

TM gone! Agree, about time.

I lost all confidence in him after the M drama, followed by the IP drama and then following a new transformation and launch of S&C and then at the first commercial update of S&C after six months( was it, longer.) they announced

“ to date through the DTC platform have been disappointing and slower to develop than initially estimated with sales of 177 units, generating £12,400 in revenue (£20,300 in revenue at full RRP before discounts and offers).”

That statement above showed lack of common sense, lack of business skill in not changing sales approach during period rather than wait six months to announce disappointment..shows no concern for business spend

I can see INC going private ….a bit of a red flag imo that the new guy is now keeping the company afloat with a £250,000 loan , which will need paying back, and there is a good chance INC will not be making 250,000 net profit and will not be able to do this , new guy takes company as repayment or part of.

All new guy needs to do is ensure company continue to try , drag it out, think of reasons for missed targets and continue to fail miserably over next couple of years…..until run out of funds ……

Notice how tight nit these characters are, no new faces here, all connected via there shared involvements….gl vas

Well...

ask is more up

wonder if its ticking...like a lit fuse...

or if it means nowt. we shall see.

Thanks nice1

i guessed the same

they probably ran out of money a while ago and are keeping the show on the road themselves while they see if they can get a partnership soon and i appreciate that, the sales were disappointing but we are where we are - if you take what they say at face value then there are 3 interested parties and if they structure it by buying product up front that we supply then we could get out of jail completely or at least not needing as much funding - i am always half glass full but resigned also to it not working as i want!

the interesting point was that a fourth party was carrying out randomised study on the product which usually is quite expensive and not often done in this market which suggests to me that it is a serious player - unfortunately that is a hard bar to pass rarely done but a good sign that someone likes the science which is hard for me to assess but was the reason for investing . for example Boots No7 Protect & Perfect serums are clinically proven to reduce wrinkles, Studies show a reduction in the appearance of fine lines and wrinkles, improved skin tone and radiance, and increased firmness and the product i think as a direct result it did very well as a result

so we just wait and hope but i hope that the final outcome is on how well the product works not it never getting to market and maybe all the parties are waiting for the trial to end? so good luck to all

and then we have a sun cream eventually to potentially launch also which might be a different sales channel or include say vitamin d so maybe more of a mass market product at a lower price point? so we just wait

Email from company.

We are working incredibly hard behind the scenes to try and there is activity surrounding much you have mentioned here.

It’s frustrating that things take so long, we had hoped to say much more by the time we needed to update the market.

Please know we are all working hard, it’s been the longest rollercoaster and we are all so personally, emotionally and professionally invested, we are working hard towards a next announcement with more commercial substance.

All guess work, as we are never told what is really going on with this company. Not sure why Marinauld walked away as the S&C cream product was there idea, was supposed to be unique and it’s not like the mystery company holding the shared IP could bring out an exact same equivalent cream, is it? Maybe they can.

What if the undisclosed company that made the IP claims against INC and subsequently settled for shared IP now wish to buy out INC , if so they get the current s&C creams, the full IP under their control and everything else that INC currently claim to hold.

Most employees these days have to have a six month, and annual appraisals..to fathom how they are doing, are they achieving their aims and targets and if not, why….its something they should introduce with all BODs on AIM and have a selection of investors doing the appraising and handing out the rewards and the layoffs .

This past years appraisal of INC, the BODs and the S&C products sales is a rock bottom failure….most employees displaying such failure in their posts would either be removed or demoated….not here though.

I think it has all flowed from the withdrawal of the partnership with Marannaud. if some one ipoed now and said they had a cream for skin cancer, a sun protection cream and they had a face serum for dark spots that is ready for sale but needs marketing then i think you could get a valation of 20m for the IP - on the basis that it will either fail or make a lot of money but sentiment has gradually gone away and we need a partnership deal so very frustrating as i dont feel we fully know how the products will do and most of the pharma here do not get to product launch

My understanding was that incanthera were focused on a medical cream for skin cancer and it was actually Marinnaud that told them to develop the face serum as it was easier and quicker to get to market so they were not spreading themselves too thinly

On the patent arguments there was either a misunderstanding or agrument and the patents had to be shared or they did not agree with the claim but the timing just as they had spent the money on the new product meant they were in a difficult postion if it could take years so they agreed to no payments but maybe some sharing of the patents? - that is all guess work but you then go to the agreements asking for non disclosure clauses and so all a bit unsatisfactory but can understand a bit where we are and why there is no information, why did they not make the claim much earlier - seemed designed to damage?

anyway i think there is potentially value even a lot of value here but high risk and cannot be sure

but good luck to the management who have reasonable shareholdings difficult times

Private/admin?

I think the company has languished and survived with very little cash in the past.

current mcap just over £1.3 million acc to LSE.

if I didn't have a day-job I'd be pouring over the figures and wondering about the probability of someone injecting some £.

I buy the odd tranche with pocket money but that doesn't really count for much.

Which of the products actually sold……was it across range? I’m guessing it wasn’t.

I feel betrayed by the claims of it selling well and aspirations of clearing stock, when they knew nothing was selling. They lack respect for us all and even themselves.

It should now be rebranded ‘skin minus sells’!

The big claims of the marketing strategy….which confirmed my previous comments about targeting the wrong demographic. The lack of explanation for the marinaud deal collapse. Reluctance to explain the benefits in terms the public understand. The complete disregard for company origins and underhand change from a cancer drug research company to a cosmetic retailer. Weaker reputation than Del Boy in the markets!

I have a small (misguided) hope they self reflect and pull something out of the bag…..but only on the basis that they have so much of their own tied up in the company.

Definitely should have updated the market sooner as mentioned on here,very poor.

What does the university think of this situation.

Need a global partner for the suncream to lift this.

Well I’m currently in Mexico and the missus brought all the skin cell products we had bought. The heat is immense and I’ve been using the body cream as an after sun (I know it’s not its intended use) and it’s working better than any after sun I’ve used.

Imo skin cells deep regenerative property’s seem to be fully taking the tenderness out of any sunburn and really hydrating the skin. I know they intend on doing an spf range so if that’s the case I am very confident it would be a big success. Looking forward to an update here and hopefully we have sold out of current stock and already producing more. The share price would immediately push onto 10-20 p imo.

Possibly all sold out.Overdue some numbers.

Strange,all of mine have been bang on estimated delivery date.

Still not received order - still chasing but getting no response

Tapman,

Did you ever get the S&C products you ordered at Xmas that never turned up ?

If not, then a good profit for S&C but not so sure of the repeat orders situation :)

The radio silence is quite worrying indeed. By looks of things on social media, the promotional campaign in there has slowed down or been given up on entirely. What about an update on selling the 100,000 units??

That’s worrying.

Also more worrying is not a single trading update issued by this dodgy lot!

Is my experience unique? Placed an order in early December for Skin +Cell product, still waiting. Is this something else that has yet to be delivered?

Actually it is not AIM. It is a acquis!

Even more shady !!!

With no news (that I can find), why the 30% increase in the SP? Bonkers, but this is AIM!

My thanks, are due to you, Volmer, for drawing attention to the FOUR Due Dates for the publication of Quarterly Trading Updates.

It is incumbent upon the Directors to either produce such statements in a timely fashion, or to retract that commitment. Shareholders can look to corporate and other advisers to a Company to do their best to ensure that client companies comply with market rules and practice.

I trust the Directors to communicate thoroughly, professionally and without favour with ALL Shareholders to ensure impartiality.

Looking forward to an interesting Trading Update in a couple of weeks' time.

At the Annual General meeting the chairman said that quarterly trading updates will be issued to include sales in units and in £.

This update should be issued by 20th of month IMO so we look forward to sales figures by:

20 January

20 April

20 July

20 October

IG markets showing 2.5p so it must be a glitch..

Yes Howard, I came on to ask the same question?!

My Barclays investor account shows the value of my incanthera shares as being zero. Has anyone else got this? I had written off this investment because of TM’s total inability to deliver anyway, but am still surprised it has come about in this way.

@xviolet , well he also managed to raise funds on IMM, and then abandoned key promises immediately after receiving the funds. We'll see what transpires here also.

@cowbridge , objectively speaking can you name a single deal delivered by Tim in any company over the last 5 to 10 years?

It seems to me both icn and imm are in a similar boat

have massive potential but both need a partner announced which will would change sentiment

somethings are beyond the control of the management so we will just have to see what happens and what interest they get

but plenty of potential

I doubt INCAN will ever have the marketing budget to make this retail strategy effective - although I haven't researched the sector, so that is just a guess. I still think this is just a PR strategy to attract licensing partners and a way of un-loading the stock they produced for Marionaud/Watson. I don't suppose the company has talked about the sell by date on this stock and their plans to produce more stock....? That kind of information would perhaps give us some clues.

Augustinus bader story is that he was a skin scientist and i think was working on burn victims

sk2 story was that it just worked and was noticed in the facotory

viagra was for blood pressure but had side effects

maybe our story is that we were researching skin cancer and by accident we found that that patients skins improved! Maybe like the website to tell a story if possible to ensnare loyalty and why you have to have the product

The christmas sale has started with 25% off

I notice augustinus bader now sell their cream from £77 though it is only 15ml not 30 so much more expensive but slightly cheaper than us due to small size but we have cheap hand creams but then they go for their elixir at 435 for 30 ml so they have offered a wide range of pricings it would be good eventually to widen the price of the serum and the eye cream from the rest of the products which you can discount a lot and push on instagram but probably not at the moment while we look for sales

i also note when you click on the ab science heading you get the choice of 6 separate pages 1 about the product company 2 trials 3 about the founder 4 about the current research 4 blog 5 press releases 6 sustainability and ethics - for me the web site needs to stand alone separate to the advertising and the channels and really persuade you to need to buy the product and read a lot about it

i remember a prodcut 20 odd years ago that you could buy in harrods from japan called the sk2 essense and their story was they noticed that factory workers that made sake had very young hands and it was one of the products from the fermentation of the sake that had caused this so we just have to tell a really good story while we wait for, it is still going song and they sell one bottle every 2 seconds apparently but i have always loved the story behind it

My girlfriend has just received the cream and the serum - the packaging in a white box and the gold bottle have always been good. it is now in a grey tray box of dark red crumpled paper contrasting well against the smaller white boxes holding the cream, with a discount code card showing a swiss lake and i think the look has improved it and it really looks classy and lush - so i think they have incrementally improved the look and it is really good she is a big spender and she thought it was a classy product could add a booklet or something i liked the before and after photos on the genaura web site

personally i would eventually raise the price of the serum but offer heavy discount online for the face cream and the other products so you have basically 2 separate markets

There is an article in todays times about a fitness influencer grace beverley who launched a fitness plan book on social media on boxing day a few years back selling for £35 when she had about 100,000 followers and by the end of january she had 80,000 profit so think we need to just get pricing and marketing right and we need to find the right influencers but still everything to play for, she now has over 2.2 million on line followers and her wellness brand is worth 70 million

Have they released any?

however potential deals and collaborations - that IMO is where the value/£ is.

good to see that mentioned. all highly speculative. but that is how it is in some comps- highly speculative, high risk etc.

anyway...in time....

I find it telling that according to the recent RNS the face creams are the best selling products, and they are the most expensive at £149 for the face cream and £213 for the face serum!

“ The data shows that our most successful marketing is via Instagram and our most successful product is B3 Face.”

I do agree. If the profit margins allow then it should be made more affordable. It’s a great product that once is a known name will sell on volume not so much larger profit margins.

Not greatly received, a loss more this time round then this time last year.

It is very good product, I also use it and bought more on the black Friday offer, I still think they should reduce the price further so more can afford it.

They should try to get middle ground so it is more affordable.

Lets hope the beginning of next year our revenue starts to show.

Rns today this summary from zaks traders cafe

Incanthera (AQSE:ICA), the company focused on innovative technologies in dermatology and oncology, presented its interim results for the six months ended 30 September 2025. ICA said “This period has seen the launch of our Skin+CELL skincare range launched globally via our dedicated Direct To Consumer website www.skinandcell.com. Establishing any new brand into a marketplace takes time, however, since launch, we have seen steady increases month on month, in traction across social media, hits to our website and conversion to sales. This is recognised in the positive feedback we have received from all users of the product range, unanimous in its praise on the dramatic effects on their skin, across all demographics.”

Comment: Having tried the product I can say that it really should be on sale at more than just the company’s website. It should be a Boots / Superdrug job. It will be difficult to get traction however good the Skin+CELL is, without mainstream distribution and awareness.

i dont mind it starting slowly but a very good product and it should be able to get the deals it needs now makes a big difference to have a prdduct actually on sale with customer feedback available, month on month sales increases and expanded marketing but we wait for real news, i think you can do suprisingly well using instagram and direct to customer with no bricks and mortar and you get a better margin but you need sales to plough back into marketing and promotion so it has to build slowly but you do not necessarily need to sell at the chemist but that would work as well

i see medik8 as well as online sell through cult beauty sephora and space nk so it should gradually happen higher sales allows higher marketing that allows higher sales hopefully, would like a few more pages on the science on the website but that could come with the planned launch of the sun protection cream

The sunscreen scandal shocking Australia - the world's skin cancer hotspot!

I was totally unaware of this scandal.

This article is a fascinating, if scary read but highlights the sweet spot that INCs S&C could be involved in , if they are able as they have hinted at bring out a scientifically tested, medical sun cream, that can be bought over the counter .

"She learned the sunscreen she had been using for years was unreliable and, according to some tests, offered next to no sun protection at all.

Independent analysis by a trusted consumer advocacy group has found that several of Australia's most popular, and expensive, sunscreens are not providing the protection they claim to, kicking off a national scandal.

There has been a massive backlash from customers, a probe launched by the country's medical watchdog, multiple products pulled from shelves, and questions raised about the regulation of sunscreen around the globe.

It's definitely not an issue isolated to Australia," cosmetic chemist Michelle Wong told the BBC."

https://www.bbc.co.uk/news/articles/c4gzl41rpdqo

Hope this is not too off topic but while we are waiting for results i sit around and think!

but i have come across this app Weshop they launched in the uk and it is like a cash back site but you get shares in them. so they have signed up a lot of the main retailers like tui shein and dorothy perkins and the way it works is i think you spend say a hundred pounds with a company but go through the weshop app they then pay back say £5 pounds to weshop and then weshop give you £2.50 in weshop shares so you share in the rebate

anyway they did a soft launch in the uk without advertising with over a £100 million in sales in the first year but early days but they have set up the model and infrastructure . they just floated on nasdaq and are valued at over $1 billion as this model could become a viable rival to say amazon anyway they needed to float as they had to offer american listed shares if they were to go into the us market and they have signed up a lot of the american retailers

the reason i write this is i thought that it would be good for skin and cell to try and join the weshop app, sure it is early days but the high nasdaq valuation means that they will have the funds to expand and we do not need much sales from any channel to a make a big difference to our share price, i see for example bloomingdales has just joined the site so this is for all products including high end sellers and i am not sure to what extent we are selling in the usa at the moment

anyway just a thought but think the app is worth checking out they may need a certain level of sales for a company to join but we are listed and it was developped in tandom with as watson so it is the sort of product the weshop shoppers should have access to

you need to be referred to join weshop so feel free to use the @cowbridge code i konw its a pleasure your welcome

Thanks' Cowbridge

I am liking these simple, direct and positive statements that S&C are now using in their publicity. They are simple, yet very effective and anyone interested enough in the product would then investigate the science further.

Recently on Instagram ..

"The Most Advanced Skin Care on Earth" !

and

"We are shaking Up a Billion Dollar Industry. Yes, We Are That Confident !"

Good stuff. Keep it up INC.

Maybe you cannot make any claims but i think i would try the cream as not sure of any better alternative creams on the market and especially in sunny places like australia

I cant find the article on line but here is a link to 2015

https://www.dailymail.co.uk/health/article-3081570/Daily-dose-vitamin-B3-slash-risk-common-skin-cancers-quarter-study-kind-reveals.html

you can i think overdose on b3 which is why the face cream has a higher dose over a small area than the body cream that is at a lower dose but then the face is more exposed to the sun and so must i guess be a higher risk area - no expert on this but i think interesting as skin and cell may just be better at actually delivering the b3 than other similar creams on the market

A bit more activity on instagram nice adverts about shaking up the industry and you dont need any other cream

I see on page 40 of todays Daily Mail they write

The most common cancers in the world are skin cancers BCC and SCC and both are driven by sun exposure, my dermatologist advised two of my patients with skin cancers recently removed to take Nicotinamide B3 twice daily from now on as there is strong evidence it reduces the risk of all three types of skin damage so the writer goes on to say that anyone who has any of the above cancers is urged to take Nicotinamide ad infinitum but maybe people at greater risk who have not had skin cancer such as fair skin or red hair should also consider taking it

We know that the current formulation of skin + cell delivers b3 as deep into the skin as any cream currently on the market obviously this is a cosmetic not making any medicinal claims but the market will hopefully realise while more expensive than tablets it has the advantage of getting the b3 to exactly where it is needed, i know of skin specialists who recommend the oat cream Aveeno brand for excema not a medicine but still recommended to customers in some cases as a useful tool in prevention

Sure a bit niche but actually skin cancer affects 3 in 10 people who are fair skinned at some time in their life so this is in fact a very large market just on its own

What’s special about this product is that it’s not just another run of the mill skin cream product , like dozens of others , but is a pharma quality, science based , proven skin cream combined with a unique / novel delivery system which reach into the parts of the skin that other products do not!

If S&C was registered as a pharma product it would be on prescription only - But instead, it’s now easily accessible because S&C is sold as an over the counter product…….so should be much more effective than its competitor's in the over the counter industry and easier to get hold of once it’s proven to work on your skin.

As you have stated a violet. If the products can be known as a product with medical efficacy but in a easy to buy over the counter industry form then the sales could escalate accordingly, just need to get to that tipping point , very early days here but company already chose to announce an initial target of 100, 000 units sold in four more months…..they did not need to do this, but chose to nail their confidence to the masts.

I’m expecting , as we have been advised yet another sales channel to be announced, hopefully in December.

If the product makes your skin look younger and if that word gets out then the product will be unstoppable

Doing €45Billion a year in revenue.

What would happen if a certain range of creams took the market by storm and really gained traction amongst celebrity’s?

I wonder what price tag you could apply to a range that is proving it could be very problematic to (L’Oréal’s or other co’s)future revenues…

Great work, cowbridge 👍 well spotted

Https://www.zerohedge.com/geopolitical/us-switzerland-reach-tariff-deal-lowers-duties-stokes-investment

Swiss tariff to USA cut from 39 to 15% which I assume covers skin + cell

Just watched the presentation.

Https://m.youtube.com/watch?v=ZQOFpD87Loc

I thought it was a good presentation and was struck by the confidence of the board. They were at no times defensive. They said "there is an opportunity to build a very, very big company here". The message was things are going well and a lot of exciting things are happening in the background. I also liked the happy interaction between shareholders and the board - to me this again reflected confidence of the board in that things are going well.

It was interesting to hear some shareholders experience in using the products. They said they had both seen benefits in healing skin after keratosis treatment. This has been my experience as well, its so good to try products of an investment and find that they do what they say they do and more!

Looking for downsides, marketing is not a company strength, oncology and development of medical and cosmetic products is. Sales figures may reflect this. But if they hit the sales of 100,000 units that they said they expect, than that would be really good.

Back to 10p region in the next week or two imo

Https://www.eventbrite.co.uk/e/aquis-showcase-tickets-1733700999359?aff=oddtdtcreator

incanthera presenting again which is good

Two years ago this month in Nov. 23 the share price here was 6p , that was before the Marinauld contract was announced. The share price consequently rose to approx. 30p. This was on no revenue. The SP then fell back down to approx. 2p on the cancellation of the M contract, and no revenue.

Today, the SP is approx. 4p a 33% discount to the 6p and with revenue expected to be announced sometime over the next few weeks / months.

What is exciting is that at some point between today and March 26, INC ( if they get remotely anywhere near their targets of sales of 100k units_) will become profitable !!

Any further inclining, let alone announcement that sales are going well and the sp will react strongly IMO.

At £10 cost per unit, and Total operating expenses of INC last year approx. £2 million - anyone care to figure how many units will need to be sold to break even! GL Vas

Obviously, must have something to add to the recent investor presentation which was only a few weeks ago.....otherwise why bother repeating.......if it was all going well just a few weeks ago - then should be some positive news , hopefully .

Probably need the money for xmas or do not believe the story…a bit late to bail imo.

INC are presently building up their brand ambassadors and influencers reaching to around 100 million consumers….and this is to be increased.

With one percent giving one million customers ….maybe to much to expect … do the maths using fractions of one percentage…still fantastic returns at just at one tenth of one percentage at 100,000 customers…that’s around one customer per 1000 viewings ….which with a decent product should be reachable, surely.

Madness to be honest with you!

Why on earth would anyone be selling at these levels…

In fairness management own quite a lot of shares so will be down too

but if there is a discount then retail investors should be allowed to subscribe

I guess if shares are issued especially as we are at the pivot point there should be no warrants and they should be at a current premium to the share price but hopefully nothing or not much is issued

i note AEG massive, and tower resources 15% discount, did fund raising with quite large discounts even thought the future looks bright which was very very disappointing

so fingers crossed we do not anymore funds

It is nice to see a lot more trades today, lets hope this continues

Hi Rookie,

IG will not let me buy any shares under 50,000 - but will charge me 4.75 for 50,000 and 100,000 !

IMO it will not be long (as soon as further news is released - new distributors!, or new products! ) and the 4.75 p will be smashed.

I can’t buy anything here this morning? MMS have no shares whatsoever

Can’t see funding more stock being a problem even if only half the stock is sold.

The potential here is huge, if marketed right it could become a global name and be worth hundreds of millions.

This is a one of a kind skin care product that once you get into the hands of the right celebrity it almost becomes a trend to use it.

And from my research so far I havnt found anything that rivals the science of skin+cell.

The only other treatments I have found to gain similar or deeper levels of rejuvenation require actually courses for treatment at clinics over 6-8 week periods.

Skin+cell products seem very effective, very convenient, and in comparison very cheap.

This should be very big one day I think.

From memory each S&C unit was costed at £10 to manufacture ( happy to be corrected) so if they are in a position of selling out of units then they would have already taken payment at time of purchase from their online shop so I think cash flow should not be a problem for existing offering .

I guess The funding of the anticapeted new lines will come either from sales of S&C units, a short term loan ( £5 million was in place last year, I think), or a fundraise …

I don't think it will take long before this moves back to 10p+.

Like he said a few times, it is now moving from a loss making company to a profitable business, and to even talk about dividends is quite a statement!

One thing that stood out for me was Tim stating there are others ways to market / to sell the product, not just via the DTC channel and “we are actively exploring these as we speak” and over next period we will be putting updates out and “ some of them are quite innovative..so watch this space”

So it does look like to me there will be various new channels to market for the S&C products announced sometime soon.

Plus a new range of products with SPF in them…. So, looking forward if all goes well there are excellent opportunities here to grow income alongside the DTC channel with new sales channels for S&C as well as new range of products again with new sales channels. gL Vas

He then goes on

Hi Rookie, you should look and research CRTX

I’m in. Just had to pay an extortionate spread and pay 3.5p for £10k of shares but I beleive incanthra is a 10x from here quite easily. And if marketing takes off there’s no reason why this couldn’t be big. £100m + mcap.

I'm still amazed they were able to get the recent raise away. Mind you I haven't watched the recent presentation. I assumed he got the raise away because there is another deal like Watson's in the pipeline? Or something better than selling through Instagram etc. I suppose if the placees are dumping then we know there is nothing in the pipeline. Or at least that is how I see it.

The unicorn VCT are just clearing out. Obviously thoroughly annoyed with how this played out (like the rest of us are no doubt)

3.4p to buy and barely 2p to sell - no wonder no one’s buying.

Market makers are clearing up !

What a mad price to sell! I am in the same boat as you happily take as much as possible if it was 1.5p!

16-Oct-25 10:57:23 1.40 500,000 Sell* 2.00 3.50 7,000 O

If anyone elase has shares to sell at 1.4p contact me and I will take all you have and pay 1.5p.